Carcinoma in situ of larynx
ICD-10 D02.0 is a billable code used to indicate a diagnosis of carcinoma in situ of larynx.
Carcinoma in situ of the larynx is a localized form of cancer characterized by the presence of abnormal cells that have not invaded surrounding tissues. This condition is often detected during routine examinations or imaging studies, and it is crucial to differentiate it from invasive laryngeal cancers. The larynx, or voice box, plays a vital role in breathing, producing sound, and protecting the trachea against food aspiration. Carcinoma in situ may present with symptoms such as hoarseness, difficulty swallowing, or a persistent cough, although many patients may be asymptomatic. Surveillance protocols typically involve regular laryngoscopic examinations and biopsies to monitor for any signs of progression to invasive cancer. The risk of progression to invasive carcinoma varies, with some studies suggesting that untreated carcinoma in situ can progress in approximately 10-30% of cases. Early detection and intervention are critical to improving patient outcomes and preventing the development of more advanced disease.
Detailed laryngoscopic findings, biopsy results, and treatment plans.
Patients presenting with hoarseness, throat pain, or abnormal findings on imaging.
Ensure clear documentation of the site and extent of the carcinoma in situ.
Comprehensive treatment history, including any surgical interventions or radiation therapy.
Patients undergoing surveillance after diagnosis of carcinoma in situ.
Document any changes in the patient's condition or treatment response.
Used for initial diagnosis and surveillance of carcinoma in situ.
Document findings from the laryngoscopy and any biopsies performed.
Otolaryngologists should ensure thorough documentation of the procedure and findings.
Carcinoma in situ is a critical diagnosis as it indicates the presence of abnormal cells that have not invaded surrounding tissues. Early detection and treatment can prevent progression to invasive cancer, which has more severe implications for patient health.
